- SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal…
Number of the records: 1  

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance

  1. TitleSB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
    Author Barančík Miroslav 1962- SAVSRDCE - Ústav pre výskum srdca SAV
    Co-authors Boháčová Viera 1964- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV
    Kvackajova J.
    Hudecová Soňa 1956- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV
    Križanová Oľga 1960- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV
    Breier Albert 1957- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV
    Source document European Journal of Pharmaceutical Sciences. Vol. 14, no. 1 (2001), p. 29-36
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2001
    DOI 10.1016/S0928-0987(01)00139-7
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.